Quantumzyme Corp. (OTC: QTZM), a biotransformation company specializing in sustainable enzyme-based solutions, announced progress on strategic initiatives including a planned 4-for-1 forward stock split and a corporate rebranding to Quantum Genesis AI Corp. The moves are designed to better position the company for its next phase of development, according to a press release on February 9, 2026.
The Board of Directors has authorized a forward stock split that will increase the number of outstanding shares while proportionally adjusting the per-share trading price. The company intends to submit the split to the Financial Industry Regulatory Authority (FINRA) only after completing the name and trading symbol change, which is in its final stages. The new name reflects a strategic focus on advancing enzyme innovation through artificial intelligence, computational modeling, and data-driven research.
President Naveen Kulkarni stated, “Our planned corporate rebranding and capital structure initiatives are intended to better align the Company’s public market profile with its long-term strategic direction.” He emphasized that completing the name and symbol change first establishes a clear foundation, and the proposed forward stock split is designed to support a more efficient and accessible public share structure.
The forward split is intended to enhance the company’s public market profile by recalibrating its capital structure, facilitating greater flexibility, and supporting administrative efficiency in trading. The company believes this action may provide potential benefits for future corporate initiatives, though it will not change overall market capitalization. Proportional ownership interests of existing shareholders will remain largely unaffected, except for minor adjustments due to fractional shares.
Quantumzyme focuses on green chemistry, using quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts for pharmaceutical manufacturing. The company aims to enhance efficiency, reduce waste, and support environmentally responsible production. More information is available at www.quantumzymecorp.com and on OTC Markets at www.otcmarkets.com/stock/QTZM.
The planned forward stock split remains subject to regulatory review and approval, and there can be no assurance regarding its timing or completion. The company expects to provide additional updates through subsequent public disclosures.
